Length of initial prescription at hospital discharge and long-term medication adherence for elderly patients with coronary artery disease: A population-level study

Canadian Journal of Cardiology

Volumn 29, Issue 11, 2013, Pages 1408-1414

  Ivers, Noah M ^a,b   Schwalm, J D ^c,d   Jackevicius, Cynthia A ^e,f,g,h,i   Guo, Helen ⁱ   Tu, Jack V ^i,j   Natarajan, Madhu ^c,d,k  

^a WOMEN S COLLEGE HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c HAMILTON GENERAL HOSPITAL   (Canada)

^d MCMASTER UNIVERSITY   (Canada)

^e WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

^f VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^g UNIVERSITY HEALTH NETWORK   (Canada)

^h UNIVERSITY OF TORONTO   (Canada)

ⁱ INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^j UNIVERSITY OF TORONTO   (Canada)

^k Cardiac Care Network of Ontario   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL OBSERVATION; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITAL DISCHARGE; HUMAN; HYPERTENSION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; OUTPATIENT CARE; PATIENT COMPLIANCE; PRESCRIPTION; PRIMARY MEDICAL CARE; RETROSPECTIVE STUDY;

ADRENERGIC BETA-ANTAGONISTS; AGE FACTORS; AGED; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; COHORT STUDIES; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DRUG PRESCRIPTIONS; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LOGISTIC MODELS; MALE; MEDICATION ADHERENCE; PATIENT DISCHARGE; RETROSPECTIVE STUDIES; SECONDARY PREVENTION; SEX FACTORS; TIME FACTORS;

EID: 84886954197     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2013.04.009     Document Type: Article

References (40)

1. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002, 106:3143-3421. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).
2. Genest J., McPherson R., Frohlich J., et al. 2009 CCS Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult-2009 recommendations. Can J Cardiol 2009, 25:567-579.
3. Smith S.C., Benjamin E.J., Bonow R.O., et al. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update. Circulation 2011, 124:2458-2473.
4. Newby L.K., LaPointe N.M., Chen A.Y., et al. Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease. Circulation 2006, 113:203-212.
5. Hudson M., Richard H., Pilote L. Parabolas of medication use and discontinuation after myocardial infarction-are we closing the treatment gap?. Pharmacoepidemiol Drug Saf 2007, 16:773-785.
6. Shalev V., Chodick G., Silber H., et al. Continuation of statin treatment and all-cause mortality: a population-based cohort study. Arch Intern Med 2009, 169:260-268.
7. Shah N.D., Dunlay S.M., Ting H.H., et al. Long-term medication adherence after myocardial infarction: experience of a community. Am J Med 2009, 122:961.e7-961.e13.
8. Rasmussen J.N., Chong A., Alter D.A. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA 2007, 297:177-186.
9. Rublee D.A., Chen S.Y., Mardekian J., et al. Evaluation of cardiovascular morbidity associated with adherence to atorvastatin therapy. Am J Ther 2012, 19:24-32.
10. Levy A.R., O'Brien B.J., Sellors C., Grootendorst P., Willison D. Coding accuracy of administrative drug claims in the Ontario Drug Benefit database. Can J Clin Pharmacol 2003, 10:67-71.
11. Jackevicius C.A., Paterson J.M., Naglie G. Concordance between discharge prescriptions and insurance claims in post-myocardial infarction patients. Pharmacoepidemiol Drug Saf 2007, 16:207-215.
12. Juurlink D., Preyra C., Croxford R., et al. Canadian Institute for Health Information Discharge abstract database: a validation study 2006, Institute for Clinical Evaluative Sciences, Toronto, ON.
13. Quan H., Sundararajan V., Halfon P., et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005, 43:1130-1139.
14. Williams J.I., Young W. Asummary of studies on the quality of health care administrative databases in Canada. Patterns of Health Care in Ontario: the ICES Practice Atlas 1996, 339-345. Canadian Medical Association, Ottawa, Canada. 2nd ed. V. Goel, J.I. Williams, G.M. Anderson (Eds.).
15. Lee D.S., Stitt A., Wang X., et al. Administrative hospitalization database validation of cardiac procedure codes. Med Care 2013, 51:e22-e26.
16. Wilkens R. Automated geographic coding based on the Statistics Canada postal code conversion files 2001, Statistics Canada, Ottawa, ON, Report No. 82F0086-XDB.
17. Benner J.S., Glynn R.J., Mogun H., et al. Long-term persistence in use of statin therapy in elderly patients. JAMA 2002, 288:455-461.
18. Jackevicius C.A., Mamdani M., Tu J.V. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA 2002, 288:462-467.
19. Kulkarni S.P., Alexander K.P., Lytle B., Heiss G., Peterson E.D. Long-term adherence with cardiovascular drug regimens. Am Heart J 2006, 151:185-191.
20. Schneeweiss S., Seeger J.D., Maclure M., et al. Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. Am J Epidemiol 2001, 154:854-856.
21. Lopez-Carmona D., Bernal-Lopez M., Mancera-Romero J., et al. Compliance with cardiovascular drug prevention measures in a general population: the multidisciplinary intervention in primary care (IMAP) study. Eur J Prev Cardiol 2012, 19:1074-1081.
22. Steele L.S., Glazier R.H., Lin E., Evans M. Using administrative data to measure ambulatory mental health service provision in primary care. Med Care 2004, 42:960-965.
23. Katz M.H. Multivariable Analysis: A Practical Guide for Clinicians and Public Health Researchers 2011, Cambridge University Press, Cambridge, UK. 3rd ed.
24. Bell C.M., Brener S.S., Gunraj N., et al. Association of ICU or hospital admission with unintentional discontinuation of medications for chronic diseases. JAMA 2011, 306:840-847.
25. Batal H.A., Krantz M.J., Dale R.A., Mehler P.S., Steiner J.F. Impact of prescription size on statin adherence and cholesterol levels. BMC Health Serv Res 2007, 7:175.
26. Steiner J.F., Robbins L.J., Roth S.C., Hammond W.S. The effect of prescription size on acquisition of maintenance medications. JGen Intern Med 1993, 8:306-310.
27. Osterberg L., Blaschke T. Adherence to medication. NEngl J Med 2005, 353:487-489.
28. Austin P.C., Tu J.V., Ko D.T., Alter D.A. Use of evidence-based therapies after discharge among elderly patients with acute myocardial infarction. CMAJ 2008, 179:895-900.
29. Ivers N.M., Schwalm J.D., Grimshaw J.M., et al. Delayed educational reminders for long-term medication adherence in ST-elevation myocardial infarction (DERLA-STEMI): protocol for a pragmatic, cluster-randomized controlled trial. Implement Sci 2012, 7:54.
30. Adherence to Long-Term Therapies: Evidence for action 2003, World Health Organization, Geneva, Switzerland. E. Sabate (Ed.).
31. Bagnall A.J., Yan A.T., Yan R.T., et al. Optimal medical therapy for non-ST-segment-elevation acute coronary syndromes: exploring why physicians do not prescribe evidence-based treatment and why patients discontinue medications after discharge. Circ Cardiovasc Qual Outcomes 2010, 3:530-537.
32. Sud A., Kline-Rogers E.M., Eagle K.A., et al. Adherence to medications by patients after acute coronary syndromes. Ann Pharmacother 2005, 39:1792-1797.
33. Ho P.M., Bryson C.L., Rumsfeld J.S. Medication adherence: its importance in cardiovascular outcomes. Circulation 2009, 119:3028-3035.
34. AB E., Denig P., van Vliet T., Dekker J.H. Reasons of general practitioners for not prescribing lipid-lowering medication to patients with diabetes: A qualitative study. BMC Fam Pract 2009, 10:24.
35. Hickling J., Rogers S., Nazareth I. Barriers to detecting and treating hypercholesterolaemia in patients with ischaemic heart disease: primary care perceptions. Br J Gen Pract 2005, 55:534-538.
36. Coleman E.A., Smith J.D., Raha D., Min S.J. Posthospital medication discrepancies: prevalence and contributing factors. Arch Intern Med 2005, 165:1842-1847.
37. Anderson J.L., Adams C.D., Antman E.M., et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction. JAm Coll Cardiol 2007, 50:e1-157.
38. Daugherty S.L., Ho P.M., Spertus J.A., et al. Association of early follow-up after acute myocardial infarction with higher rates of medication use. Arch Intern Med 2008, 168:485-491.
39. Kripalani S., LeFevre F., Phillips C.O., et al. Deficits in communication and information transfer between hospital-based and primary care physicians: implications for patient safety and continuity of care. JAMA 2007, 297:831-834.
40. Lemstra M., Blackburn D., Crawley A., Fung R. Proportion and risk indicators of nonadherence to statin therapy: a meta-analysis. Can J Cardiol 2012, 28:574-580.